New inhaler combo shows promise for Tough-to-Control asthma
NCT ID NCT01577082
First seen Mar 22, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study tested a new inhaler (CHF 1535) that combines a steroid and a long-acting bronchodilator against a standard steroid-only inhaler in 542 adults whose asthma was not well controlled with their current medications. The goal was to see if the combination inhaler improved morning lung function more than the steroid alone over 12 weeks. Results help doctors understand better treatment options for persistent asthma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiesi Clinica Trial Site
Witten, 58452, Germany
-
Chiesi Clinica Trial Site
Yaroslavl, 150030, Russia
-
Chiesi Clinical Trial
Perpignan, 66000, France
-
Chiesi Clinical Trial SIte
Sofia, 1618, Bulgaria
-
Chiesi Clinical Trial SIte
Varna, 9010, Bulgaria
-
Chiesi Clinical Trial Site
Plovdiv, 4004, Bulgaria
-
Chiesi Clinical Trial Site
Plovdiv, 4023, Bulgaria
-
Chiesi Clinical Trial Site
Rousse, 5402, Bulgaria
-
Chiesi Clinical Trial Site
Rousse, 7002, Bulgaria
-
Chiesi Clinical Trial Site
Sofia, 1000, Bulgaria
-
Chiesi Clinical Trial Site
Sofia, 1407, Bulgaria
-
Chiesi Clinical Trial Site
Sofia, 1510, Bulgaria
-
Chiesi Clinical Trial Site
Sofia, 1606, Bulgaria
-
Chiesi Clinical Trial Site
Stara Zagora, 6000, Bulgaria
-
Chiesi Clinical Trial Site
Troyan Municipality, 5600, Bulgaria
-
Chiesi Clinical Trial Site
Varna, 1510, Bulgaria
-
Chiesi Clinical Trial Site
Mělník, 27601, Czechia
-
Chiesi Clinical Trial Site
Neratovice, 27711, Czechia
-
Chiesi Clinical Trial Site
Prague, 14000, Czechia
-
Chiesi Clinical Trial Site
Toulon, 83000, France
-
Chiesi Clinical Trial Site
Berlin, 10117, Germany
-
Chiesi Clinical Trial Site
Berlin, 12043, Germany
-
Chiesi Clinical Trial Site
Bonn, 53119, Germany
-
Chiesi Clinical Trial Site
Düren, 52349, Germany
-
Chiesi Clinical Trial Site
Hamburg, 20251, Germany
-
Chiesi Clinical Trial Site
Leipzig, 04207, Germany
-
Chiesi Clinical Trial Site
Leipzig, 04357, Germany
-
Chiesi Clinical Trial Site
Magdeburg, 39112, Germany
-
Chiesi Clinical Trial Site
Radebeul, 01445, Germany
-
Chiesi Clinical Trial Site
Saarbrücken, 66111, Germany
-
Chiesi Clinical Trial Site
Schwabach, 91126, Germany
-
Chiesi Clinical Trial Site
Budapest, H-1122, Hungary
-
Chiesi Clinical Trial Site
Dabas, 2370, Hungary
-
Chiesi Clinical Trial Site
Deszk, 6772, Hungary
-
Chiesi Clinical Trial Site
Gödöllő, 21100, Hungary
-
Chiesi Clinical Trial Site
Komárom, 2900, Hungary
-
Chiesi Clinical Trial Site
Pécs, 7624, Hungary
-
Chiesi Clinical Trial Site
Siófok, 8600, Hungary
-
Chiesi Clinical Trial Site
Százhalombatta, 2440, Hungary
-
Chiesi Clinical Trial Site
Szolnok, 5000, Hungary
-
Chiesi Clinical Trial Site
Padova, 35013, Italy
-
Chiesi Clinical Trial Site
Parma, 43125, Italy
-
Chiesi Clinical Trial Site
Pisa, 56124, Italy
-
Chiesi Clinical Trial Site
Pordenone, 323170, Italy
-
Chiesi Clinical Trial Site
Verona, 37134, Italy
-
Chiesi Clinical Trial Site
Bialystok, 15025, Poland
-
Chiesi Clinical Trial Site
Bialystok, 15274, Poland
-
Chiesi Clinical Trial Site
Bienkówka, 34200, Poland
-
Chiesi Clinical Trial Site
Gdansk, 80847, Poland
-
Chiesi Clinical Trial Site
Giżycko, 11500, Poland
-
Chiesi Clinical Trial Site
Gmina Jędrzejów, 28300, Poland
-
Chiesi Clinical Trial Site
Katowice, 40752, Poland
-
Chiesi Clinical Trial Site
Katowice, 40952, Poland
-
Chiesi Clinical Trial Site
Lodz, 90153, Poland
-
Chiesi Clinical Trial Site
Lodz, 92107, Poland
-
Chiesi Clinical Trial Site
Lublin, 20718, Poland
-
Chiesi Clinical Trial Site
Ostróda, 14100, Poland
-
Chiesi Clinical Trial Site
Ostrów Wielkopolski, 63400, Poland
-
Chiesi Clinical Trial Site
Rzeszów, 35051, Poland
-
Chiesi Clinical Trial Site
Moscow, 109147, Russia
-
Chiesi Clinical Trial Site
Moscow, 117593, Russia
-
Chiesi Clinical Trial Site
Saratov, 410000, Russia
-
Chiesi Clinical Trial Site
Birmingham, B15 2SQ, United Kingdom
-
Chiesi Clinical Trial Site
Chorley, PR7 7NA, United Kingdom
-
Chiesi Clinical Trial Site
Manchester, M15 6SE, United Kingdom
-
Chiesi Clinical trial
Marmande, 47200, France
Conditions
Explore the condition pages connected to this study.